Double-blind comparison of doxazosin and enalapril in patients with mild or moderate essential hypertension
- 31 January 1991
- journal article
- clinical trial
- Published by Elsevier in American Heart Journal
- Vol. 121 (1) , 299-303
- https://doi.org/10.1016/0002-8703(91)90862-c
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Stratifying the patient at risk from coronary disease: New insights from the framingham heart studyAmerican Heart Journal, 1990
- Serum lipid changes in a one-year, multicenter, double-blind comparison of doxazosin and atenolol for mild to moderate essential hypertensionThe American Journal of Cardiology, 1987
- Multicenter, double-blind comparison of doxazosin and atenolol in patients with mild to moderate hypertensionThe American Journal of Cardiology, 1987
- Changing perspectives in the prevention of coronary artery diseaseThe American Journal of Cardiology, 1986
- EnalaprilDrugs, 1986
- Multicentre 12‐week double‐blind comparison of doxazosin, prazosin and placebo in patients with mild to moderate essential hypertension.British Journal of Clinical Pharmacology, 1986
- A long‐term double‐blind comparison of doxazosin and atenolol in patients with mild to moderate essential hypertension.British Journal of Clinical Pharmacology, 1986
- Acute and chronic haemodynamic effects of doxazosin in hypertension at rest and during exercise.British Journal of Clinical Pharmacology, 1986
- Clinical pharmacological studies with doxazosin.British Journal of Clinical Pharmacology, 1986
- A pharmacodynamic and pharmacokinetic assessment of a new alpha‐ adrenoceptor antagonist, doxazosin (UK33274) in normotensive subjects.British Journal of Clinical Pharmacology, 1982